Septoplasty Clinical Trial
Official title:
Silastic Sheet Usefulness Following Septoplasty
| NCT number | NCT04921462 |
| Other study ID # | RC20/509 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | September 29, 2020 |
| Est. completion date | May 4, 2021 |
| Verified date | June 2021 |
| Source | King Abdulaziz Medical City |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study aimed to evaluate the effectiveness of silastic septal splint in reducing the rates of complications, decreasing the post-operative pain, and improving satisfaction in comparison to quilting suturing technique. Methods: A single center randomized controlled trial, including adult above the age of 18. A total of 50 participants who underwent septoplasty were enrolled and randomly assigned into two groups, Silastic group (n=25), and quilting group (n=25). Nasal obstruction severity was assessed by using an Arabic validated version of NOSE score, preoperatively then 3 days, one week and one month postoperatively. Post-operative complications were assessed at outpatient clinic 1 week and 1 month postoperatively. Pain was assessed by a 10-point numerical scales via phone call on the 3rd day postoperative.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | May 4, 2021 |
| Est. primary completion date | March 31, 2021 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Adult (= 18 years) healthy individuals of both genders with deviated nasal septum and no other concomitant procedures. Exclusion Criteria: - 1. Concomitant procedure other than septoplasty. 2. Previous history of septal or nasal surgery. 3. Presence of nasal polyps, chronic sinusitis or other regional pathology. 4. Bleeding disorders or anticoagulation therapy. |
| Country | Name | City | State |
|---|---|---|---|
| Saudi Arabia | King Abdulaziz Medical City | Riyadh |
| Lead Sponsor | Collaborator |
|---|---|
| King Abdulaziz Medical City |
Saudi Arabia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in NOSE score 1 month postoperatively | NOSE change = preoperative NOSE - 1 month postoperative NOSE | 1 month postoperatively | |
| Secondary | Validated NOSE score | NOSE score preoperatively, 3 days, 1 week and 1 month postoperatively | ||
| Secondary | complications | Bleeding, Bad smell, Synechia, Crustation and Perforation | 1 month | |
| Secondary | postoperative pain | using numerical Pain scale (0 to 10) | at 3 days postoperative | |
| Secondary | general satisfaction questionnaire | at 1 month postoperative |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04392583 -
Safety and Performance of ENTACT Septal Staple System for Septoplasty
|
||
| Recruiting |
NCT04020367 -
Validation of a Process for the Manufacture of Stem Cells Isolated From the Nasal Cavity for Innovative Cell Therapy of Traumatized Peripheral Nerves
|
N/A |